537 related articles for article (PubMed ID: 32438606)
21. Increased Expression of Exosomal AGAP2-AS1 (AGAP2 Antisense RNA 1) In Breast Cancer Cells Inhibits Trastuzumab-Induced Cell Cytotoxicity.
Zheng Z; Chen M; Xing P; Yan X; Xie B
Med Sci Monit; 2019 Mar; 25():2211-2220. PubMed ID: 30910994
[TBL] [Abstract][Full Text] [Related]
22. Evaluating the expression of tumorigenic long noncoding RNAs in circulating exosomes isolated from non-small-cell lung cancer patients.
Shi Z; Huang K; Li Z; Niu Y; Jiang L
Biomark Med; 2022 Mar; 16(4):241-251. PubMed ID: 35209738
[No Abstract] [Full Text] [Related]
23. Long Non-Coding RNAs in Diagnosis, Treatment, Prognosis, and Progression of Glioma: A State-of-the-Art Review.
Momtazmanesh S; Rezaei N
Front Oncol; 2021; 11():712786. PubMed ID: 34322395
[TBL] [Abstract][Full Text] [Related]
24. Exosomal microRNAs and exosomal long non-coding RNAs in gynecologic cancers.
Hashemipour M; Boroumand H; Mollazadeh S; Tajiknia V; Nourollahzadeh Z; Rohani Borj M; Pourghadamyari H; Rahimian N; Hamblin MR; Mirzaei H
Gynecol Oncol; 2021 Apr; 161(1):314-327. PubMed ID: 33581845
[TBL] [Abstract][Full Text] [Related]
25. Long noncoding RNA dysregulation in ischemic heart failure.
Greco S; Zaccagnini G; Perfetti A; Fuschi P; Valaperta R; Voellenkle C; Castelvecchio S; Gaetano C; Finato N; Beltrami AP; Menicanti L; Martelli F
J Transl Med; 2016 Jun; 14(1):183. PubMed ID: 27317124
[TBL] [Abstract][Full Text] [Related]
26. The role of exosomal lncRNAs in cancer biology and clinical management.
Zhang W; Wang Q; Yang Y; Zhou S; Zhang P; Feng T
Exp Mol Med; 2021 Nov; 53(11):1669-1673. PubMed ID: 34819615
[TBL] [Abstract][Full Text] [Related]
27. Exosomal MALAT1 derived from hepatic cells is involved in the activation of hepatic stellate cells via miRNA-26b in fibrosis induced by arsenite.
Dai X; Chen C; Xue J; Xiao T; Mostofa G; Wang D; Chen X; Xu H; Sun Q; Li J; Wei Y; Chen F; Quamruzzaman Q; Zhang A; Liu Q
Toxicol Lett; 2019 Nov; 316():73-84. PubMed ID: 31513886
[TBL] [Abstract][Full Text] [Related]
28. Modulation of long non-coding RNAs by resveratrol as a potential therapeutic approach in cancer: A comprehensive review.
Asemi R; Rajabpoor Nikoo N; Asemi Z; Shafabakhsh R; Hajijafari M; Sharifi M; Homayoonfal M; Davoodvandi A; Hakamifard A
Pathol Res Pract; 2023 Jun; 246():154507. PubMed ID: 37196467
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of exosomal long non-coding RNAs in lung cancer.
He L; Lin M; Shen J; Qi H
Mol Biol Rep; 2022 Jun; 49(6):4989-4997. PubMed ID: 35083616
[TBL] [Abstract][Full Text] [Related]
30. The role of lncRNAs and exosomal lncRNAs in cancer metastasis.
Zhang Y; Zhao L; Bi Y; Zhao J; Gao C; Si X; Dai H; Asmamaw MD; Zhang Q; Chen W; Liu H
Biomed Pharmacother; 2023 Sep; 165():115207. PubMed ID: 37499455
[TBL] [Abstract][Full Text] [Related]
31. Long non-coding RNAs in retinoblastoma.
Yang M; Wei W
Pathol Res Pract; 2019 Aug; 215(8):152435. PubMed ID: 31202519
[TBL] [Abstract][Full Text] [Related]
32. Association of well-characterized lung cancer lncRNA polymorphisms with lung cancer susceptibility and platinum-based chemotherapy response.
Gong WJ; Yin JY; Li XP; Fang C; Xiao D; Zhang W; Zhou HH; Li X; Liu ZQ
Tumour Biol; 2016 Jun; 37(6):8349-58. PubMed ID: 26729200
[TBL] [Abstract][Full Text] [Related]
33. Interplay of long non-coding RNAs and TGF/SMAD signaling in different cancers.
Farooqi AA; Attar R; Qureshi MZ; Fayyaz S; Sohail MI; Sabitaliyevich UY; Nurmurzayevich SB; Yelekenova A; Yaylim I; Alaaeddine N
Cell Mol Biol (Noisy-le-grand); 2018 Dec; 64(15):1-6. PubMed ID: 30672446
[TBL] [Abstract][Full Text] [Related]
34. Long Noncoding RNAs in Pathological Cardiac Remodeling: A Review of the Update Literature.
Zhou H; Wang B; Yang YX; Jia QJ; Zhang A; Qi ZW; Zhang JP
Biomed Res Int; 2019; 2019():7159592. PubMed ID: 31355277
[TBL] [Abstract][Full Text] [Related]
35. The roles of exosomal miRNAs and lncRNAs in lung diseases.
Li Y; Yin Z; Fan J; Zhang S; Yang W
Signal Transduct Target Ther; 2019; 4():47. PubMed ID: 31728212
[TBL] [Abstract][Full Text] [Related]
36. Tumor‑released lncRNA H19 promotes gefitinib resistance via packaging into exosomes in non‑small cell lung cancer.
Lei Y; Guo W; Chen B; Chen L; Gong J; Li W
Oncol Rep; 2018 Dec; 40(6):3438-3446. PubMed ID: 30542738
[TBL] [Abstract][Full Text] [Related]
37. Emerging long noncoding RNA polymorphisms as novel predictors of survival in cancer.
Abdi E; Latifi-Navid S
Pathol Res Pract; 2022 Nov; 239():154165. PubMed ID: 36257235
[TBL] [Abstract][Full Text] [Related]
38. Exosomal RNAs: Novel Potential Biomarkers for Diseases-A Review.
Wang J; Yue BL; Huang YZ; Lan XY; Liu WJ; Chen H
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269604
[TBL] [Abstract][Full Text] [Related]
39. Tumor-Derived Exosomal Long Noncoding RNAs as Promising Diagnostic Biomarkers for Prostate Cancer.
Wang YH; Ji J; Wang BC; Chen H; Yang ZH; Wang K; Luo CL; Zhang WW; Wang FB; Zhang XL
Cell Physiol Biochem; 2018; 46(2):532-545. PubMed ID: 29614511
[TBL] [Abstract][Full Text] [Related]
40. The functional roles of exosomes-derived long non-coding RNA in human cancer.
Chen F; Wang N; Tan HY; Guo W; Zhang C; Feng Y
Cancer Biol Ther; 2019; 20(5):583-592. PubMed ID: 30739532
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
